| USD millions | FY2021 | FY2022 | FY2023 | FY2023 | FY2025 | FY2025 | TTM | Trend | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.3 | 3.9 | 0.3 | 0.0 | 2.0 | 2.1 | 1.9 | −8.4% | |
| Cost of revenue | — | — | — | 0.0 | — | — | — | — | |
| Gross profit | — | — | — | 0.0 | — | — | — | — | |
| Research & development | 56.4 | 37.6 | 6.0 | 1.5 | 0.3 | 1.0 | 1.6 | +66.5% | |
| Operating expenses | 83.6 | 59.1 | 18.8 | 13.0 | 5.6 | 7.0 | 8.7 | +23.8% | |
| Operating income | (81.3) | (55.2) | (18.5) | (13.0) | (3.6) | (5.0) | (6.8) | −37.2% | |
| Interest expense | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Pre-tax income | (122.4) | (51.6) | (44.1) | (5.3) | (3.1) | (3.5) | (6.7) | −90.1% | |
| Income tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Net income | (77.8) | (51.6) | (44.1) | (5.3) | (3.1) | (3.5) | (6.7) | −90.1% | |
| EPS, basic (per share) | — | (1.32) | (20.28) | (2.25) | (1.21) | (1.11) | (2.93) | −164.3% | |
| EPS, diluted (per share) | — | (1.32) | (20.28) | (2.25) | (1.21) | (1.11) | (2.93) | −164.3% | |
| EBITDA | (79.0) | (54.7) | (18.5) | (13.0) | (3.6) | (5.0) | (6.8) | −37.2% | |
| Depreciation & amortization | 2.3 | 0.5 | 0.1 | 0.0 | — | — | — | — | |
| Weighted average shares (shares) | — | 39,144,000 | 2,173,000 | 2,338,000 | 2,518,000 | 3,181,000 | — | — | |
| Weighted average diluted shares (shares) | — | 39,144,000 | 2,173,000 | 2,338,000 | 2,518,000 | 3,181,000 | — | — | |
| Operating margin | −3,539.4% | −1,400.2% | −6,242.4% | — | −181.4% | −239.8% | −359.2% | −119.4 pts | |
| Net margin | −3,388.6% | −1,310.2% | −14,841.1% | — | −152.9% | −170.1% | −353.0% | −182.9 pts |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
TTM ends 2026-06-30 and uses four consecutive reported quarters.
